Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients.

MLA

Lanigan, Fiona, et al. “Delineating Transcriptional Networks of Prognostic Gene Signatures Refines Treatment Recommendations for Lymph Node-Negative Breast Cancer Patients.” The FEBS Journal, vol. 282, no. 18, Sept. 2015, pp. 3455–73. EBSCOhost, https://doi.org/10.1111/febs.13354.

APA

Lanigan, F., Brien, G. L., Fan, Y., Madden, S. F., Jerman, E., Maratha, A., Aloraifi, F., Hokamp, K., Dunne, E. J., Lohan, A. J., Flanagan, L., Garbe, J. C., Stampfer, M. R., Fridberg, M., Jirstrom, K., Quinn, C. M., Loftus, B., Gallagher, W. M., Geraghty, J., & Bracken, A. P. (2015). Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients. The FEBS Journal, 282(18), 3455–3473. https://doi.org/10.1111/febs.13354

Chicago

Lanigan, Fiona, Gerard L Brien, Yue Fan, Stephen F Madden, Emilia Jerman, Ashwini Maratha, Fatima Aloraifi, et al. 2015. “Delineating Transcriptional Networks of Prognostic Gene Signatures Refines Treatment Recommendations for Lymph Node-Negative Breast Cancer Patients.” The FEBS Journal 282 (18): 3455–73. doi:10.1111/febs.13354.